Skip to main content

Table 2 Characteristics of the matched study population in the SA-1

From: Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients

  

Surgery

 

CCRT

 

Standardized differencea

  

Number or mean (sd)a

(%)a

Number or mean (sd)a

(%)a

Age

 

57.00 (7.63)

 

56.61 (9.62)

 

0.05

Gender

Female

6

(5)

3

(3)

0.14

Male

104

(95)

107

(97)

 

Residency

Non-north

76

(69)

80

(73)

0.08

North

34

(31)

30

(27)

 

Tumor size

≤ 5 cm

43

(39)

42

(38)

0.02

> 5 cm

67

(61)

68

(62)

 

Differentiation

Poorly/undifferentiated

41

(37)

42

(38)

0.02

Well/moderately

69

(63)

68

(62)

 

RT delivery

Non-IGRT

94

(85)

96

(87)

0.05

IGRT

16

(15)

14

(13)

 

Institution

Low volume

40

(36)

45

(41)

0.09

High volume

70

(64)

65

(59)

 

Use of PET

Without

12

(11)

12

(11)

0.00

With

98

(89)

98

(89)

 

Location

Cervical

1

(1)

1

(1)

0.00

Noncervical

109

(99)

109

(99)

 
  1. sd standard deviation, RT radiotherapy, IGRT image-guided RT, PET positron emission tomography, CCRT concurrent chemoradiotherapy
  2. aRounded